Noom logo

Noom Review

7.1
★★★★☆3.6/5

Semaglutide GLP-1 weight-loss telehealth · Independently scored 7.1/10

Best for: people who want GLP-1s, brand or compounded, paired with Noom's psychology-based habit app and coaching

Noom scores highest on the strength of its clinical program: drug options and dosing support.

Semaglutide

$249/mo · 3-month plan rate

Price checked on Noom's site,

What the monthly price covers

Medication

Not stated

Provider visits

Included

Shipping

Not stated

Lab work

Not stated

Coaching

Included

See plans →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

Behavioral weight-loss app that also prescribes GLP-1s. Its GLP-1Rx Program (medication included) is $129 to start, then $249 a month billed quarterly; brand Zepbound is self-pay through LillyDirect on top of the $129/mo Noom Med fee.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
SemaglutideTirzepatide

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

Vetted alternatives to Noom

7.7/ 10
Partner

Ro

Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

★★★★☆3.9/5

Editorial score · methodology

$149/mosemaglutide
+ required membership
BrandSemaglutideTirzepatideOrforglipron
Get StartedRead full Ro review →
8.3/ 10
Partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★☆4.2/5

Editorial score · methodology

$59/mosemaglutide
+ required membership
$69/motirzepatide
+ required membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.3/ 10
Partner

CoreAge Rx

Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

★★★★☆4.2/5

Editorial score · methodology

$79/mosemaglutide
starting price
$129/motirzepatide
starting price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →
Noom logo
3.6 / 5
Our editorial rating
Visit Noom →

from $249/mo · no insurance needed

Noom at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$249/mo (3-month plan rate)
What's included
Consult · Coaching
FDA status
No FDA warning letter on record

How we scored Noom

Each dimension is scored algorithmically from Noom'spublished pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.

Value25%

6.2/10

Noom's headline is $249 a month on a 3-month plan. Compare it with other programs on the same plan basis.

Effectiveness25%

8.4/10

Noom offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. FDA-approved brand options are available alongside compounded versions.

User Experience15%

7.1/10

Online intake and platform experience (consult included in the price); 2 platform features disclosed.

Trust & Safety15%

7.3/10

Core details confirmed by our editors; no FDA warning letters on file.

Accessibility10%

6.1/10

Noom's exact state footprint isn't published. Confirm coverage in your state before signing up.

Support10%

7.2/10

Coaching/dietitian access included.

6scored dimensions
679providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this Noom review

Last checked November 2026
  • Confirmed current pricing across 2 dose/plan tiers and 1 separate fee
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the provider's public sign-up flow, stopping before payment

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.

What we checked

Provider's own pricing page
$179–$249/mo across 2 dose/plan tiers, plus a $299/mo fee that excludes the medication (checked November 2026)
FDA warning-letter register
No letter on file for this provider

What to expect when you sign up with Noom

We walked Noom's public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Take a quick quiz to customize the program.
  2. 2A medical clinician evaluates eligibility.
  3. 3Clinician prescribes a GLP-1 if clinically appropriate.
  4. 4Medication is shipped to your door.
Price shown before you start
  • Pricing shown up front: the GLP-1Rx Program is $129 to start, then $249/mo billed quarterly; the Microdose plan is $79, then $179/mo.
  • Medication 'shipped to your door in just 7 days'; availability varies and not available in all 50 states.
  • Support via 24/7 live-agent chat and email; phone noted as under maintenance.
  • Excludes users under 18, pregnant individuals, those with eating disorders, or BMI below 18.5.
  • No refund/cancellation policy stated on the page reviewed.

GLP-1 medications Noom offers

Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.

Pricing

Prices re-verified

GLP-1Rx Program: compounded semaglutide, billed quarterlyCompounded
$249/mo
semaglutide

$129 for the first 4-week supply, then $249 a month billed quarterly. Includes medication, clinical care and the Noom program.

Noom Med + self-pay Zepbound vials (LillyDirect), medication onlyFee — not a medication price
$299/mo

Noom's Zepbound page: 'self-pay Zepbound® vials starting at $299/mo', fulfilled through LillyDirect. Medication only: the Noom Med subscription ('$39 to get started, then $129/month for ongoing care') is billed separately and 'The cost of medication is not included in the Noom Med subscription.'

Microdose GLP-1Rx: compounded semaglutide, billed quarterlyCompounded
$179/mo
semaglutide

$79 for the first 4-week supply, then $179 a month billed quarterly, not month to month.

Ready to get started?

Plans and promotions change often, so check Noom's current pricing and active discounts before you decide.

See Noom pricing →

What we like

  • Both semaglutide and tirzepatide available

Watch-outs

  • After the first 4 weeks, medication plans are billed quarterly, not month to month

Noom Med: the weight-loss app that grew a prescription pad

Most people meet Noom long before they think about a GLP-1. It started as the psychology-driven food-logging app with the cheerful color-coded meals and the daily coaching nudges, and that history is the single most important thing to understand about it. Noom Med is the clinical add-on bolted onto a behavior-change platform, not a standalone telehealth pharmacy. If you want a medication and nothing else, Noom is an odd fit. If you want a semaglutide or tirzepatide prescription wrapped inside a structured habit program you'll use, that combination is what it's built to sell.

What you can be prescribed

Noom Med is unusually broad on the medication side. Noom's GLP-1 page lists the full slate of brand-name GLP-1s (Wegovy, Zepbound, Ozempic, and Mounjaro), plus the oral Wegovy pill and plain metformin for people who want to start gentler or cheaper. On top of that it offers a compounded "Microdose GLP-1" track and a separate brand-name access path. That's a wider menu than many app-first competitors, which tend to push one compounded formulation and call it a day. Noom also owns OpenRx, a separate brand that sells prescription peptides such as NAD+ and sermorelin rather than GLP-1s.

  • Brand-name injectables: Wegovy, Zepbound, Ozempic, Mounjaro
  • Oral options: the Wegovy pill and metformin
  • Compounded route: a low-dose "Microdose GLP-1" plan as a lower-cost entry point

How the pricing works: three paths, billed quarterly

Noom publishes its prices on a pricing page, and the cost depends on which path you pick. The GLP-1Rx Program is $129 for the first 4-week supply, then $249 a month, with medication, clinical care and the app included. The Microdose plan is $79 to start, then $179 a month. Both are billed quarterly after the first four weeks, so you pay three months at a time rather than month to month. The brand-name route works differently: Noom Med is $39 to start and $129 a month for care, and the medication is extra. Self-pay Zepbound vials through LillyDirect start at $299 a month on top of that fee.

For context, the category median sits around $179 a month. Noom's GLP-1Rx Program costs more than that, and the brand route adds the care fee to the drug price. Compare the all-in figure for your path against a flat-rate competitor, and see our scoring methodology for how we weigh price.

How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 129 programs that publish one.

The coaching is the differentiator, not the pharmacy

Strip away the medication and what's left is still a serious product, and that's the point. Every medication plan includes full access to the core Noom app, plus what the company describes as on-demand one-to-one support and coaching and unlimited chat with its doctors. For someone who has rebounded after past diets, that wraparound (the logging, the lessons, the human in your pocket when a craving hits at nine at night) is the reason to pick Noom over a bare-bones script mill. The drug suppresses appetite, and the app is supposed to rebuild the habits so the loss sticks when you eventually taper off.

Who should choose Noom, and who should walk

Choose Noom if you're a mainstream patient who wants the medication and the behavioral scaffolding in one subscription, and who finds app-based accountability helpful. It's a comfortable on-ramp for first-timers who'd rather not assemble a clinic, a coach, and a pharmacy separately.

  • Good fit: people who want medication plus structured habit coaching, GLP-1 first-timers, anyone who already likes the Noom app
  • Poor fit: price-shoppers who want to pay month to month at a below-median rate; people who only want a prescription with no app or coaching attached; anyone who dislikes daily-engagement programs. If you live in Texas and paying with no contract matters more to you, VitaFusions IV charges one price at any dose with no membership or autodraft, though it has no online checkout

Trust, oversight, and the gaps

Noom carries no FDA warning letters, and it's a large, well-known consumer-health company rather than a fly-by-night brand. Both are points in its favor. But two gaps keep it out of the top tier. First, it does not publicly disclose which states it serves; its fine print says only that it is not available in all 50 states, so confirm coverage in your own state before assuming you can sign up. When confirmed 50-state coverage is your priority, Nucore Health is a physician-owned, LegitScript-certified clinic serving every state, though its prices sit behind an intake quiz. Second, the plans bill quarterly after the first four weeks, which locks in three months of cost at a time. Neither is a safety red flag, but both are friction you should know about going in.

The bottom line

Noom Med is a credible, broad-menu GLP-1 option whose main value is the behavior-change program around the prescription, not a bargain price. If you want the app-plus-medication bundle and you're willing to confirm your state and total cost yourself before paying, it's a reasonable mainstream pick. If you just want the cheapest transparent script, a flat-rate cash-pay competitor will serve you better. Check the current price for your specific plan on Noom's pricing page before you commit, since Noom has changed these numbers before.

The Bottom Line

Noom scores highest on the strength of its clinical program: drug options and dosing support.

Score: 7.1/10Best for: people who want GLP-1s, brand or compounded, paired with Noom's psychology-based habit app and coachingFrom: $249 a month on a 3-month plan

Ready to start with Noom?

From $249 a month on a 3-month plan. See current pricing and start your online intake.

Head-to-head

Compare Noom vs…

Noom scores7.1/10

Side-by-side pricing, medications and scores. Pick a matchup.

Scores are our independent editorial ratings out of 10.

Frequently Asked Questions

Noom is mainly a behavior-change app built around psychology-based lessons, food logging, and habit coaching. Noom Med is the clinical layer that connects you with licensed clinicians who can prescribe GLP-1 medication when it is appropriate. You can use the app on its own, but the prescriptions come through the Noom Med program.
Noom's GLP-1Rx Program, which includes compounded semaglutide, clinical care and the app, is $129 for the first 4-week supply and then $249/month, billed quarterly. The Microdose GLP-1Rx plan is $79 to start and then $179 a month, also billed quarterly. For brand-name medication, Noom Med is $39 to start and $129/month for care, and the medication is extra: self-pay Zepbound vials through LillyDirect start at $299/mo. Confirm current pricing during intake.
Noom Med only prescribes after a licensed clinician reviews your health history, and every medication plan includes unlimited chat with its doctors plus 1:1 coaching for follow-up. GLP-1 medications are prescription drugs with contraindications and side effects, so safety depends on appropriate screening and ongoing monitoring. Always discuss your full history with the prescribing clinician before starting.
Both. Noom Med can prescribe FDA-approved brand-name options such as Wegovy, Zepbound, Ozempic, and Mounjaro (and an oral Wegovy pill), as well as a compounded Microdose GLP-1. Keep in mind that compounded GLP-1 medications are not FDA-approved as finished products, so weigh that trade-off with your clinician.
Noom is most worth it if you want the behavior-change coaching and app alongside your medication rather than a medication-only service. Every medication plan bundles full app access, on-demand 1:1 coaching, and unlimited doctor chat, which is the platform's main differentiator. If you only want the lowest possible medication price with no coaching, a stripped-down telehealth provider may cost less.
Yes. Noom states that all medication plans include full access to the Noom app, including its psychology-based lessons, tracking tools, and habit support. The coaching and app are designed to work together with the medication rather than replace it.
Noom does not publish a full list of states on its site, and GLP-1 telehealth availability can change over time. The most reliable way to confirm coverage is to start the intake, which checks eligibility for your location.
Noom doesn't use public promo or coupon codes. Third-party sites advertising "Noom discount codes" are typically fake; any current offer applies automatically through the link on this page.
Noom is an operating telehealth provider, and we found no FDA warning letter on file for it. Its public pages don't show a LegitScript certification or the name of the pharmacy that fills its prescriptions. We last checked its prices and policies on its own site in November 2026. We scored it 7.1/10 from published information, which is not a clinical endorsement. Talk to a licensed clinician before starting any medication.
We don't collect customer complaints, so this covers what our own review found. There is no FDA warning letter on file for Noom. The concerns our review flags: After the first 4 weeks, medication plans are billed quarterly, not month to month. Weigh them before you sign up.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this Noom review:

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  4. 4.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.

See Noom's current pricing

Plans from $249 a month on a 3-month plan. Start the online intake to check eligibility and today's price.